Fertility Treatment Safe for Breast Cancer Survivors With BRCA Mutations
(MedPage Today) -- In young BRCA carriers who survived breast cancer, assisted reproductive techniques (ART) did not increase the risk of disease recurrence or adversely affect pregnancy outcomes, findings of an international cohort study suggested... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 17, 2024 Category: Endocrinology Source Type: news
More Evidence Supports Active Surveillance for Low-Risk Papillary Thyroid Cancer
(MedPage Today) -- Conversion surgery after active surveillance for low-risk papillary thyroid carcinoma (PTC) led to no clinically meaningful differences in outcomes as compared with immediate surgery, according to a matched cohort study.
Complication... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 17, 2024 Category: Endocrinology Source Type: news
South Park Takes on Wegovy; Decapitated Doc's Killer Sentenced; Deadliest Superbugs
(MedPage Today) -- Note that some links may require registration or subscription.
A new special of the TV show "South Park" will take on the rising use of weight-loss drugs. (People)
Nearly 900,000 Yogi Echinacea Immune Support teabags are being... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 17, 2024 Category: Endocrinology Source Type: news
Obesity Mystery Solved: The Reversible Cause You Never Knew
(MedPage Today) --
Internal medicine and rheumatology specialist Siobhan Deshauer, MD, solves the mystery case of Leslie, a woman who experienced unexplained weight gain and a host of other symptoms.
Following is a partial transcript of the... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 16, 2024 Category: Endocrinology Source Type: news
Smartphone-Based Lifestyle Interventions Result in Modest, Sustained Weight Loss
(MedPage Today) -- Smartphone-based behavioral interventions for weight loss were more effective when they involved financial incentives or one-on-one coaching calls, two randomized trials showed.
In one trial, middle-age men with obesity who... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 15, 2024 Category: Endocrinology Source Type: news
Wegovy Perks Sustained for Years; Most Have 'CKM Syndrome'; New Adrenal Guidelines
(MedPage Today) -- One in eight U.S. adults have taken semaglutide (Ozempic, Wegovy) or another GLP-1 agonist, a KFF poll found.
Metabolic benefits of semaglutide for weight loss were sustained for several years, according to findings presented... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 14, 2024 Category: Endocrinology Source Type: news
Low Risk for New-Onset Thyroid Diseases After mRNA Vaccines
(MedPage Today) -- NEW ORLEANS -- The chance of new-onset thyroid disease after administration of mRNA COVID-19 vaccines was rare, but still noteworthy, according to a meta-analysis.
There were 77 cases of thyroid-related autoimmune diseases... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 11, 2024 Category: Endocrinology Source Type: news
Slow Responders to Zepbound Achieve Meaningful Weight Loss Eventually
(MedPage Today) -- NEW ORLEANS -- The vast majority of patients with obesity who responded slowly to the once-weekly injectable tirzepatide (Zepbound) achieved meaningful reductions in body weight a year later, a post hoc analysis of the SURMOUNT... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 10, 2024 Category: Endocrinology Source Type: news
Teprotumumab Improves Thyroid Eye Disease Across Phenotypes
(MedPage Today) -- NEW ORLEANS -- Comparable improvements were observed with teprotumumab (Tepezza) between patients with age-related phenotypic I or II thyroid eye disease, according to results from a post-hoc analysis.
At 24 weeks, 81% of... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 10, 2024 Category: Endocrinology Source Type: news
Ozempic Price Cut; Hypoparathyroidism Tx Fast Tracked; Halle Berry's Menopause Bill
(MedPage Today) -- Novo Nordisk cut the price of its blockbuster weight-loss and diabetes drug semaglutide (Wegovy, Ozempic). (Reuters)
In adults with increased fracture risk, once-weekly 1-mg semaglutide did not increase bone formation based... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 7, 2024 Category: Endocrinology Source Type: news
Fresh and Frozen Embryo Transfers May Increase Risk of Childhood Leukemia
(MedPage Today) -- While overall cancer risk was no different for children born after fertility treatments compared with those naturally conceived, frozen or fresh embryo transfer did appear to increase risk of leukemia, according to a French cohort... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 2, 2024 Category: Endocrinology Source Type: news
Hypothalamic Obesity Tx; Weekly Insulin Under Review; Ozempic Price Investigation
(MedPage Today) -- Setmelanotide, an investigational melanocortin-4 receptor agonist, reduced body mass index (BMI) by a mean 15% at 16 weeks and 26% at 12 months in people with hypothalamic obesity in a phase II open-label trial. Developer Rhythm... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 30, 2024 Category: Endocrinology Source Type: news
New T2D Guidelines; More Cushing's Relacorilant Data; Drug Shortages Rage On
(MedPage Today) -- The American College of Physicians released a new guideline for the pharmacological treatment of type 2 diabetes in adults, strongly recommending the addition of an SGLT2 inhibitor, GLP-1 receptor agonist, or DPP-4 inhibitor... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 24, 2024 Category: Endocrinology Source Type: news
Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs?
(MedPage Today) -- Bexagliflozin (Brenzavvy) and dapagliflozin (Farxiga) induced similar HbA1c reductions over 24 weeks in a head-to-head phase III trial of the SGLT2 inhibitors in Chinese adults with type 2 diabetes on metformin. (Journal of Diabetes... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 16, 2024 Category: Endocrinology Source Type: news
Type D Personality and Hypothyroidism; Infertility and eGFR; Fracture Algorithm
(MedPage Today) -- Type D personality, which is associated with negative emotions, was disproportionately represented in people with hypothyroidism, and these patients tended to experience worse treatment outcomes. (Journal of Clinical Endocrinology... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 10, 2024 Category: Endocrinology Source Type: news
